enzymology clinical significance of enzymes and isoenzymes
TRANSCRIPT
Enzymology :Clinical significance of Enzymes & Isoenzymes(Diagnostic uses and Therapeutic uses )
Dr. Rohini C Sane
Clinical significance of enzymes Enzyme units
• International units ( one micromole of substrate conversion / per minute/l of serum sample ( IU /l )
• Standard international : /SYSTEM INTERNATIONAL /KATAL (catalytic activity ) number of moles of substrate transformed /second /l of sample KAT Or K( IU= 60 MICROKATAL )
Techniques for estimation of enzymes
• Colorimetry /spectrophotometry
• Fluorometry
• RIA
• ELISA
• Chemiluminescence
Factors affecting enzyme estimations 1. Age
2. Sex
3. Pregnancy
4. Time of sampling
5. Temperature
6. p H
7. Substrate concentration
8. Product concentration
9. Presence of drugs in plasma
Therefore strict control on estimation of enzyme is needed
Enzyme appear in plasma by 3 ways1. Functional plasma enzymes
2. Non Functional plasma enzymes
3. Obstruction to secretory pathway
Functional plasma enzymes Non Functional plasma enzymes
High concentration in plasma in physiological conditions
low concentration in plasma in physiological conditions
Low concentration in tissue in physiological conditions
High concentration in tissue in physiological conditions
low concentration in plasma in pathological conditions
decreased synthesis by damaged liver cells
High concentration in plasma in pathological conditions( tissue damage )
eg Psuedocholine esterase, ipase SGPT , SGOT, LDH, CPK
Obstruction to Secretory Pathway Physiological conditions balance between synthesis & release
Pathological conditions loss of balance between synthesis & release
CONDITIONS RELATED TO INCREASED SERUM ENZYME LEVELS
Significant elevation in serum levels of enzymes is observed under following conditions :
1. Cellular damaged
2.Increase rate of cell turnover
3. Proliferation of cells
4. Increased synthesis
PRINCIPLE OF ESTIMATION OF ENZYMES BY COLORIMETRY /SPECTROMETRY
A:
I. Buffered Substrate + Serum (Enzyme) Product
II. Product + Chemical Reagent Colored Complex
III. Measurement of optical density of colored complex
B :
NADH dependent estimations using UV light as a source : increase or decrease of Absorbance
CLINICAL SIGNIFICANCE OF ENZYMES Enzyme function Normal range Occurrence Clinical significance
Aldolase F1,6 P Triose Phosphate
1.5-7.2micromoles /l Myocardium Skeletal muscles liver
Sensitive index in muscle wasting Muscular dystrophy Poliomyelitis Myasthenia Gravis
α-Amylase Starch Maltose Serum – 50-120 IU/LURINE < 375 IU /L
Salivary glandPancreasplacenta
MUMPS > 1000IU/LEctopic pregnancyAcute pancreatitis
Acid phosphatase( optimum p H)
Hydrolysis of esters of phosphoric acid
2.5 – 12 IU /L Prostrate RBC WBCPlatelet semen
PROSTRATE CANCER
FORENSIC RAPE CASE
PSA-PROSTRATE SENTSITIVE ANTIGEN
(SERINE PROTEASE ) 1 -5 MICROGRAM /L Prostrate semen( LIQUIFICATION OF COAGULUM )
PROSTRATE CANCER( > 10 MICROGRAM /L )BEFORE RECTAL EXAMINATIONBENIGN PROSTRATE ENLARGEMENT (5- 10 MICROGRAM /L )
ASPARTATE TRANSAMINASE (AST/SGOT )PRINCIPLE OF ESTIMATION OF SGOT
α KGA +Aspartate ↔ Glutamate + Oxaloacetate
↓
Pyruvate
Pyruvate +DNPH BROWN COLOR COMPLEX ( Alkaline pH )
Clinical Significance of SGPT
1. Normal range of Serum SGOT = 2-20 IU/L
2. Significant increase observed in Myocardial Infarction
3. Moderate increase observed in liver disease including Hepatoma
4. Isoenzymes –Cytosolic ( Mild Injury )/Mitochondrial (Severe Injury )
ALANINE TRANSAMINASE (ALT/SGPT )PRINCIPLE OF ESTIMATION OF SGPT
α KGA +Alanine ↔ Glutamate +Pyruvate
Pyruvate +DNPH BROWN COLOR COMPLEX (alkaline medium )
Clinical Significance of SGPT
1. Normal range of SGPT =(13-40 IU/L )
2. Significant increase observed in ACUTE HEPITITIS (100-1000 IU/L)
3. Moderate increase observed in liver disease including Hepatoma
4. Increase in Serum ALT>>>Serum AST is observed before clinical manifestation
5. Chronic Liver Diseases (25-100 Iu/L ) /Cirrhosis /Malignancy
6. Bad prognosis is indicated by SUDDEN FALL in serum levels of SGPT
Enzymes indicated Liver DiseasesHEPATIC DISEASE Enzyme of choice for diagnosis
Parenchymal diseases SGPT
Liver dysfunction, cholestasis Nucleotide Phosphatase
Obstructive Jaundice Alkaline Phosphatase
Alcoholic liver Gamma Glutamyl Trans peptidase ( γGT )
Hepatitis LDH 5
Alcoholic liver Alcohol Dehydrogenase
ENZYMES INDICATED IN HEART DISEASES
ENYZYME PATTERN IN HEART DISEASE (AMI )
CPK -MB First enzyme to increase in AMI
Aspartate Amino Transferase increase after CPK, half life 4-5days
Lactate Dehydrogenase (LDH1 ) Last enzyme to get elevated in AMI ,significant half life
ENZYMES INDICATED IN MUSCLE DISEASES
ENZYME WHICH SHOW SIGNIFICANT INCREASE IN MUSCLE DISEASES
Creatinine Phosphokinase (CPK -MM )
SGPT
Aldolase (non specific )
Enzymes Indicated In Bone Diseases
Serum Alkaline Phosphatase increases Significantly in Paget Disease, Rickets ,Hyperthyroidism.
Enzymes indicated in Prostrate Diseases
• Acid phosphatase (Tartaric acid labile ) - Prostrate Cancer ( Malignant / Benign )
• Diagnosis conformed by estimation of PROSTRATE SPECIFIC ANTIGEN (PSA )–Prostrate Cancer ( Malignant / Benign )
Enzymes indicated in Kidney Diseases
Beta Glucuronidase –for diagnosis of urinary bladder diseases
Therapeutic uses of EnzymesEnzyme Therapeutic use
1 Asparginase Acute Lymphatic Leukemia (cells need Asparagine for its growth )
2 Streptokinase LYSE INTRACELLULAR CLOT
3 Uro kinase Lyse Intracellular Clot
4 Plasminogen PLASMIN /CLOT LYSIS
5 Streptokinase DNA ase applied locally
6 Hyaluronidase Enhance local anesthesia
7 Pancreatic (Lipase & Trypsin ) Pancreatic insufficiency – oral administration
8. Papain Anti-inflammatory
9. Alpha Anti Trypsin Emphysema
Diagnostic uses of Enzymes
ENZYME FOR DIAGNOSTIC PURPOSE ESTIMATION OF
1 UREASE UREA
2 Uricase Uric acid
3 GLUCOSE OXIDASE GLUCOSE
4 PERIOXIDASE GLUCOSE /CHOLESTEROL
5 HEXOKINASE GLUCOSE
6 CHOLESTEROL OXIDASE CHOLESTEROL
7 LIPASE TRIGLYCERIDE
8 HORSE RADDISH PERROXIDASE ELISA
9 ALKALINE PHOSPHATASE ELISA
10 RESTRICTION ENDONUCLEASE SOURTHEN BLOT
11 REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION
PRINCIPLE : SUBSTRATE (SERUM )+ENZYME PRODUCT -CHEMICAL REAGENT –OD OF COLOR COMPLEX ( α CONC OF SUBSTRATE )
ISOENZYMESDefinition : Enzymes occurring in different molecular forms which differ in their
physiochemical prosperities but catalyze the same reaction
Physio-chemical properties of Isoenzymes
1. differential mobility on electrophoresis
2. differential mobility in column chromatography
3. differential kinetic properties
a. Km
b. V max
c. Optimum temperature
d. Optimum p H
e. Relative sensitivity to inhibitors
f. Degree of denaturation
Iso enzymes of Lactate dehydrogenase
Reaction is reversible & uses NAD⁺ as a coenzyme
Iso enzymes of Lactate dehydrogenase
Subunit composition of LDH isoenzymesIn heart cells conversion of Lactate to Pyruvate favored by LDH1
In muscle cells conversion of Pyruvate to Lactate favored by LDH5
Comparison of Isoenzymes of Lactate dehydrogenase
Comparison of Isoenzymes of Lactate dehydrogenase
LDH1 LDH5
Optimum condition
AEROBIC ANAEROBIC
Km high low
Affinity for pyruvate
low high
Synthesis of lactate
Not favored Favored
Iso enzymes of Lactate dehydrogenase
Electrophoretic mobility of LDH Isoenzymes
Electrophoretic mobility of Isoenzymes LDH & CPK
Clinical significance of LDH3
Iso enzymes of Lactate dehydrogenase in AMI
ENZYME HALF LIFE
LDH 1 8 DAYS
LDH 6- 8 DAYS
CPK -MB 2 DAYS
SGOT 4 DAYS
AREA UNDER CURVE ,SLOPE OF INITIAL RISE α INFARCT
Clinical significance of Isoenzymes of Lactate dehydrogenase
MECHANISMS OF ISOMERISATION OF ENZYMES
1. Genetic factors
2. Polymerization
3. Conformational isomerization
4. Presence of charged group
5. Differential gene location on same chromosome or diffirentchromosome
MECHANISM OF ISOMERISATION OF ENZYMESI.GENETIC FACTOR : LDH
-------------------------------------------H gene M gene
gene expression
^^^^^^^^^^^^^ ^^^^^^^^^^^^^^
M POLYPEPTIDE H POLYPEPTIDE
H4 H3 M H2 M2 HM3 M4
• HEART LIVER /MUSCLES
MECHANISM OF ISOMERISATION OF ENZYMESII Polymerization: eg Cholinesterase ( Type 1-5 )
Differ in surface charges differential electrophoretic mobility
Cholinesterase 5 ---(dilution ) yields 5 polypeptide chains
CHE 1 CHE2 CHE3 CHE4 CHE5
Separation of isoenzymes of Cholinesterase ( Type 1-5 ) by starch gel electrophoresis of serum
MECHANISM OF ISOMERISATION OF ENZYMES
MECHANISM OF ISOMERISATION OF ENZYMES
III Conformational isomerismIso enzymes have similar
1. Amino acid sequence
2. Active site
3. Enzymatic property
Dissimilar
1. Tertiary structure (folding of chain )
2. Electrophoretic mobility
eg Cytoplasmic Aspartate Transaminase
Microsomal Aspartate Transaminase are Conformational Isomers
MECHANISM OF ISOMERISATION OF ENZYMES
MECHANISM OF ISOMERISATION OF ENZYMES• IV PRESENCE OF CHARGED GROUPS
Isomers OF Alkaline Phosphatase differ in the number of Sialic acid residues (charged groups ) attached to enzyme –Post transcription modification
Position of alkaline phosphatase in electrophoresis location
α 2 (ALPHA 2 ) Liver
γ (GAMMA ) Intestine ( No Sialic Acid Residues )
PRE BETA Bone ( Heat Labile )
PRE BETA Placenta ( Heat Stable )
Catalysis of Alkaline Phosphatase
Optimum p H : 9- 10Function :hydrolysis of phosphoric esters Cofactors – Mg ⁺⁺,Mn ⁺⁺ ,Zn⁺⁺
Comparison of Isoenzymes of Alkaline Phosphatase
Iso enzyme of Alkaline p04 ase
Occurrence % of total Alkaline PO₄⁻ asein serum
Clinical significance ( increase in serum levels observed in )
1 α 1 Liver 10 Obstructive Jaundice ,Hepatoma
2 α 2 ( heat labile –DENATURED BY BOILING AT 65⁰ C FOR 30 MINS )
Liver 20 Hepatitis
3 α 2 ( HEAT STABLE INHIBITED BY Phe )
Placenta 10 Lung /liver/ GIT CARCINOMA
4 Pre beta heat labile Bone 5 Bone carcinoma ,Paget's, Osteitis , Osteomalacia
5 γ ( gamma )INHIBITED BY Phe
Intestinal cells 10 Ulcerative colitis
6 Leucocyte (LAP ) MYELOID LEUKAMIA ,LYMPHOMAS
Clinical significance of Isoenzymes of Alkaline Phosphatase
Electrophoretic pattern for Isoenzymes Of Alkaline Phosphatase
MECHANISM OF ISOMERIZATION OF ENZYMES
V Differential gene location on same chromosome or different chromosome
1. Salivary & Pancreatic Amylase
2. Cytosolic & Mitochondrial Malate Dehydrogenase
Iso enzymes of Creatinine phosphokinase (CPK)
• Normal range in serum( males) : 15-100 IU
• Normal range in serum (females ): 10-80 IU
Iso enzyme Abbreviation Location Elevated serum levels observed in
Electrophoretic mobility
CPK 1 CPK-BB Brain Maximum
CPK 2 CPK-MB Heart Acute Myocardial infarction
Intermediate
CPK 3 CPK-MM Muscles Muscular Dystrophy Least
CPK –MT (MITOCHONDRIAL )
Genes coding Isoenzymes of Creatinine Phosphokinase (CPK)
Electrophoretic pattern for Isoenzymes Of Creatinine Phosphokinase (CPK)
Creatinine phosphokinase (CPK) as a Cardiac marker
TROPONINS ( MARKER OF MYOCARDIAL INFARCTION )TROPONINS TYPE Property
TROPONINS C Calcium Binding
TROPONINS I ACTINO MYOCIN INHIBITORY ATPase
TROPONINS T Tropomyosin Binding Element
Comparison of Cardiacbiomarkers including CPK-MB ,LDH, Troponin, Myoglobin
Isoenzymes of Alcohol dehydrogenase
Iso enzymes of Alcohol dehydrogenase
Prevalence
α β 1 Americans
α β 2 (HIGH AFFINITY FOR ALCOHOL )
Chinese ,Japanese
Alcohol Aldehyde (Aldehyde responsible for increase heart rate---Tachycardia ,facial flashings )
Alcohol Aldehyde (Aldehyde responsible for increase in heart rate= Tachycardia, facial flashings )
Toxic effects of Ethanol
Genetic mutations in enzymes & diseases Biochemical changes in Mutation of enzyme
1. Gain in amino acids
2. Loss in amino acids
3. Replacement by another amino acids
Gene mutation defective enzyme
A. Amino acid residues from active site of enzymes altered
B. Amino acid residues from catalytic site of enzymes altered
C. Three dimensional structure of enzymes altered
D. Catalytic activity of enzymes reduced ( different Km,V max ) or lost (inactive )
Defective Enzyme –Lethal Disturbance /Mental Retardation
Remedy : capsule containing normal enzyme enter blood circulation toxic metabolites metabolized & normal products produced
Industrial Applications of Enzymes
Genetic mutations of enzymes & diseases Disease Defective enzyme
Albinism Tyrosinase
Alkaptonuria Homogenitisate Dioxygenase
Phenylketonuria Phenylalanine mono-oxygenase
Homocystinuria Cysthathione beta synthtase
Albinism is associated with the mutation of Tyrosinase
Phenylketonuria :Genetic mutations in enzymes Phenylalanine Mono oxygenase
PKU : PHENYLKETONURIA HISTORY ,SIGNS,SYMPTOMS & TREATMENT
Alkaptonuria: signs, symptoms & genetic mutation in a gene coding for enzyme Homogenistic acid oxidase
Alkaptonuria: signs, symptoms & genetic mutation in a gene coding for enzyme Homogenistic acid oxidase
Laboratory Tests for Diagnosis of Alkaptonuria
Altered Metabolic Pathway in Alkaptonuria
Genetic mutations in Tyrosine Metabolism: AlkaptonuriaandTyrosinemiaType I
Silent features of Alkaptonuria
Silent features
•Urine: turns black on standing (due to oxidation of homogentisic acid).
•On long standing urea is hydrolysed into ammonia which then reacts with
homogentisic acid in presence of oxygen to form a black pigment similar to
melanin.
•Ochronosis: Occurs due to deposition of homogentisic acid in skin and
connective tissue. Leads to bluish hue especially of the sclera and ear cartilage.
•Joints: Chronic osteoarthritis involving large joints (spine, hip, knee).
•CVS: Aortic/mitral valvulitis, myocardial infarction.
Ochronosis & Alkaptonuria
Deposition of Homogentistic acid in skin & connective tissue .Bluish hue in sclera & ear cartilage
Glucose 6 phosphate dehydrogenase (G6PD ) deficiency
HMP SHUNT ( the first step is catalyzed by G6PD)
Glucose 6 phosphate +NADP 6 Phospho Gluconolactone + NADPH **
measure in increase in absorbance at 340nm .
Glutathione (oxidized )+ NADPH ** Glutathione (reduced )+ NADP ⁺
HMP SHUNT ( the first step is catalyzed by G6PD)
Glucose 6 phosphate dehydrogenase (G6PD ) deficiencyFunctions of Glutathione (reduced )
1. Detoxify peroxides To prevent hemolytic anaemia ( peroxidation of fatty acids of cell membrane prevented )
2. To protect sulphhydryl group from oxidation
SH-SH
↓oxidation
S-S
3.to prevent meth hemoglobin formation (oxidation of ferrous into ferric inhibited
4.To impart resistance to Malaria
Glucose 6 phosphate dehydrogenase (G6PD ) deficiency
Laboratory Tests for diagnosis of Glucose 6 phosphate dehydrogenase (G6PD ) deficiency
Glucose 6 phosphate dehydrogenase (G6PD ) deficiency
Laboratory Tests for diagnosis of Glucose 6 phosphate dehydrogenase (G6PD ) deficiency
Meth haemoglobinemia in Glucose 6 phosphate dehydrogenase (G6PD ) deficiency
Meth haemoglobinemia & hemolytic anemia induced when doses of reducing drugs administerd
Meth haemoglobinemia
Meth Hb ( oxidized form ) + NADPH
Meth Hb reductase
Hemoglobin (reduced form )+ NADP⁺
Inheritance of Glucose 6 phosphate dehydrogenase (G6PD ) deficiency
• Hemizygous male (1 normal gene ,1 abnormal gene , Individuals normal)
• Homozygous female
Treatment of Glucose 6 phosphate dehydrogenase (G6PD ) deficiency
Clinical applications of Immobilized enzymes
1. Immobilized enzymes :used for detection of abnormal substances in urine
Paper coated with GOD -POD for Glucose in urine
Glucose + O2 + H2O Glucuronic acid + H2O2
H2O2 H20 + (O)
(O) + O- Toluidine ( colorless ) blue color complex( oxidized O- Toluidine )
2.GOD POD /Urease/ Amylase /Hexokinase For Diagnostic Purpose
3.Chromatography columns with activated Sepharose ( Cyanogen Bromide )& Immobilized Enzymes ( preservation of enzymes without loss of activity )
4. Immobilized enzymes + substrate PRODUCT